- Trials with a EudraCT protocol (6)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
6 result(s) found for: Casopitant.
Displaying page 1 of 1.
| EudraCT Number: 2006-000781-37 | Sponsor Protocol Number: NKV102549 | Start Date*: 2006-07-24 |
| Sponsor Name:GlaxoSmithKline Research and Development Ltd | ||
| Full Title: A Phase III, Multicenter, Randomized, Double-Blind, Active Controlled, Parallel Group Study of the Safety and Efficacy of the Intravenous and Oral Formulations of the Neurokinin-1 Receptor Antagon... | ||
| Medical condition: Chemotherapy induced nausea and vomiting (CINV) due to Moderately Emetogenic Chemotherapy (MEC) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) DE (Completed) BE (Completed) IE (Completed) SK (Completed) ES (Completed) AT (Completed) EE (Completed) CZ (Completed) LT (Completed) HU (Completed) DK (Completed) LV (Completed) GR (Completed) IT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2007-005169-36 | Sponsor Protocol Number: NKV110721 | Start Date*: 2008-02-07 |
| Sponsor Name:GlaxoSmithKline Research and Development Limited | ||
| Full Title: NKV110721, A Study of Single Dose Intravenous Casopitant in Combination with Ondansetron and Dexamethasone for the Prevention of Oxaliplatin-Induced Nausea and Vomiting | ||
| Medical condition: Prevention of nausea and vomiting due to first cycle of oxaliplatin based chemotherapy in patients with colorectal cancer receiving a combination with 5-fluorouracil and leucovorin, or in combinati... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) CZ (Completed) DE (Completed) HU (Completed) IT (Completed) SK (Completed) BG (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2006-002033-21 | Sponsor Protocol Number: NKV102551 | Start Date*: 2006-09-11 | |||||||||||
| Sponsor Name:GlaxoSmithKline Research and Development Ltd | |||||||||||||
| Full Title: A Phase III Multicenter, Randomized, Double-Blind, Active-Controlled, Parallel Group Study of the Efficacy and Safety of the Intravenous and Oral Formulations of the Neurokinin-1 Receptor Antagonis... | |||||||||||||
| Medical condition: Chemotherapy induced nausea and vomiting (CINV) due to Highly Emetogenic Chemotherapy (HEC) | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: FI (Completed) ES (Completed) IE (Completed) GR (Completed) BE (Completed) CZ (Completed) SK (Completed) HU (Completed) IT (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2006-001877-13 | Sponsor Protocol Number: TMT107235 | Start Date*: 2006-08-24 |
| Sponsor Name:GlaxoSmithKline Research & Development Ltd | ||
| Full Title: A randomised, double-blind, double-dummy, parallel-group, placebo-controlled study comparing correlates of brain functional activation before and after treatment with placebo, active comparator par... | ||
| Medical condition: Major Depressive Disorder | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: GB (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-005856-42 | Sponsor Protocol Number: NKT102553 | Start Date*: 2006-03-29 |
| Sponsor Name:GlaxoSmithKline Research and Development Ltd | ||
| Full Title: A Phase III, Multicenter, Randomized, Double-blind, Parallel Group Study to Evaluate the Safety and Efficacy of 50 mg Oral Dosing with the Neurokinin-1 Receptor Antagonist GW679769 for the Preventi... | ||
| Medical condition: Postoperative Nausea and Vomiting (PONV) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Female | |
| Trial protocol: GB (Completed) HU (Completed) DE (Completed) IE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-005855-16 | Sponsor Protocol Number: NKT102552 | Start Date*: 2006-03-20 |
| Sponsor Name:GlaxoSmithKline Research and Development Ltd | ||
| Full Title: A Phase III Multicenter, Randomized, Double-blind, Parallel Group Study to Evaluate the Safety and Efficacy of the 30 mg Intravenous Formulation of the Neurokinin-1 Receptor Antagonist GW679769 for... | ||
| Medical condition: Postoperative Nausea and Vomiting (PONV) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Female | |
| Trial protocol: BE (Completed) HU (Completed) ES (Completed) CZ (Completed) DE (Completed) | ||
| Trial results: View results | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
